Decoding that pain in the neck

Learn about neck pain causes, evaluation, management, and prevention strategies to maintain a healthy neck in the digital age ...
Rheumatology Advisor

Secukinumab Looks Promising for Polymyalgia Rheumatica

Topline data were announced from a phase 3 trial evaluating secukinumab in patients with polymyalgia rheumatica.
Medscape

JAK1 Inhibitor Shows Promise for Ankylosing Spondylitis

Ivarmacitinib, a highly selective Janus kinase 1 (JAK1) inhibitor, tamed ankylosing spondylitis with sustained efficacy through 24 weeks in a phase 2/3 trial. A phase 2/3 trial in China evaluated the ...
Nasdaq

UCB : Five-year Data On Bimekizumab In Treatment Of Ankylosing Spondylitis Shows Improvements

(RTTNews) - UCB announced new long-term data from the Bimzelx (bimekizumab) Phase 2b study BE AGILE and its open-label extension. Patients with ankylosing spondylitis treated with Bimzelx, an IL-17A ...